Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation

[1]  M. Saheed,et al.  Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder , 2023, JAMA network open.

[2]  C. Jurkovitz,et al.  Implementation of a clinical pathway to screen and treat medical inpatients for opioid withdrawal , 2022, Implementation research and practice.

[3]  S. Wakeman,et al.  Nudging Emergency Department-Initiated Addiction Treatment , 2021, Journal of addiction medicine.

[4]  H. Schmidt,et al.  Interventions for Hospitalized Medical and Surgical Patients with Opioid Use Disorder: A Systematic Review , 2021, Substance abuse.

[5]  L. Degenhardt,et al.  Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis. , 2021, JAMA psychiatry.

[6]  K. O’grady,et al.  Preventing Hospital Readmission for Patients With Comorbid Substance Use Disorder , 2021, Annals of Internal Medicine.

[7]  M. Kariisa,et al.  Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths — United States, 2013–2019 , 2021, MMWR. Morbidity and mortality weekly report.

[8]  S. Wakeman,et al.  Peer recovery coaches in general medical settings: Changes in utilization, treatment engagement, and opioid use. , 2020, Journal of substance abuse treatment.

[9]  S. Wang,et al.  Effect of inpatient medication assisted therapy on against-medical-advice discharge and readmission rates. , 2020, The American journal of medicine.

[10]  M. Lyons,et al.  Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated Buprenorphine , 2020, JAMA network open.

[11]  Wesley C. Holland,et al.  Interrupted Time Series of User‐centered Clinical Decision Support Implementation for Emergency Department–initiated Buprenorphine for Opioid Use Disorder , 2020, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[12]  D. McCarty,et al.  Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis , 2020, Journal of General Internal Medicine.

[13]  S. Wakeman,et al.  The Impact of Access to Addiction Specialist on Attitudes, Beliefs and Hospital-Based Opioid Use Disorder Related Care: A Survey of Hospitalist Physicians , 2020, Substance abuse.

[14]  P. Owens,et al.  Hospital inpatient stays related to opioid use disorder and endocarditis, 2016. , 2020 .

[15]  S. Calcaterra,et al.  A Call to Action: Hospitalists' Role in Addressing Substance Use Disorder. , 2020, Journal of hospital medicine.

[16]  Michael Lawrence Barnett,et al.  In Rural Areas, Buprenorphine Waiver Adoption Since 2017 Driven By Nurse Practitioners And Physician Assistants. , 2019, Health affairs.

[17]  Zachary F. Meisel,et al.  Barriers and facilitators for emergency department initiation of buprenorphine: A physician survey. , 2019, The American journal of emergency medicine.

[18]  S. Wakeman,et al.  Predictors for 30-Day and 90-Day Hospital Readmission Among Patients With Opioid Use Disorder. , 2019, Journal of addiction medicine.

[19]  Sylvia P. Perry,et al.  “We’ve Learned It’s a Medical Illness, Not a Moral Choice”: Qualitative Study of the Effects of a Multicomponent Addiction Intervention on Hospital Providers’ Attitudes and Experiences , 2018, Journal of hospital medicine.

[20]  L. Degenhardt,et al.  Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies , 2017, British Medical Journal.

[21]  K. Donelan,et al.  Attitudes, practices, and preparedness to care for patients with substance use disorder: Results from a survey of general internists , 2016, Substance abuse.

[22]  G. D’Onofrio,et al.  Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. , 2015, JAMA.

[23]  B. Anderson,et al.  Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. , 2014, JAMA internal medicine.

[24]  E. Brouwers,et al.  Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. , 2013, Drug and alcohol dependence.

[25]  R. D. Bruce,et al.  Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence. , 2012, Journal of substance abuse treatment.

[26]  Rosie P Cornish,et al.  Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database , 2010, BMJ : British Medical Journal.

[27]  W. Hall,et al.  Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. , 2009, Drug and alcohol dependence.

[28]  Paul S Haber,et al.  Management of injecting drug users admitted to hospital , 2009, The Lancet.

[29]  C. Cunningham,et al.  Nurse practitioner and physician assistant interest in prescribing buprenorphine. , 2008, Journal of substance abuse treatment.

[30]  T. Parran,et al.  Inpatient initiation of buprenorphine maintenance vs. detoxification: can retention of opioid-dependent patients in outpatient counseling be improved? , 2006, The American journal on addictions.

[31]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[32]  R. Andersen,et al.  The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. , 2000, Health services research.

[33]  W. Miller,et al.  Assessing drinkers' motivation for change: The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES). , 1996 .